Amur Minerals Corporation (CRTX) - Total Liabilities
Based on the latest financial reports, Amur Minerals Corporation (CRTX) has total liabilities worth GBX583.34K GBX (≈ $70.98 USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Amur Minerals Corporation (CRTX) cash flow conversion to assess how effectively this company generates cash.
Amur Minerals Corporation - Total Liabilities Trend (2016–2024)
This chart illustrates how Amur Minerals Corporation's total liabilities have evolved over time, based on quarterly financial data. Check Amur Minerals Corporation liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Amur Minerals Corporation Competitors by Total Liabilities
The table below lists competitors of Amur Minerals Corporation ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Mothercare PLC
LSE:MTC
|
UK | GBX36.40 Million |
|
Bradda Head Holdings Ltd
LSE:BHL
|
UK | GBX73.64K |
|
Contango Holdings PLC
LSE:CGO
|
UK | GBX5.65 Million |
|
Adomos SA
PA:ALADO
|
France | €11.25 Million |
|
Boostheat
PA:ALBOO
|
France | €3.20 Million |
|
The Investment Company plc
LSE:INV
|
UK | GBX72.31K |
Liability Composition Analysis (2016–2024)
This chart breaks down Amur Minerals Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Amur Minerals Corporation (CRTX) total market value.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.65 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.32 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.24 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Amur Minerals Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Amur Minerals Corporation (2016–2024)
The table below shows the annual total liabilities of Amur Minerals Corporation from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | GBX341.00K ≈ $41.49 |
-48.49% |
| 2023-12-31 | GBX662.00K ≈ $80.55 |
-13.54% |
| 2022-12-31 | GBX765.65K ≈ $93.16 |
-7.98% |
| 2021-12-31 | GBX832.07K ≈ $101.24 |
+7.91% |
| 2020-12-31 | GBX771.06K ≈ $93.82 |
-9.53% |
| 2019-12-31 | GBX852.24K ≈ $103.69 |
-69.00% |
| 2018-12-31 | GBX2.75 Million ≈ $334.48 |
+193.03% |
| 2017-12-31 | GBX938.14K ≈ $114.14 |
-75.64% |
| 2016-12-31 | GBX3.85 Million ≈ $468.54 |
-- |
About Amur Minerals Corporation
CRISM Therapeutics Corporation develops a drug delivery technology for the clinical performance of cancer treatments for solid tumors through the local delivery of chemotherapy drugs. Its lead product is ChemoSeed, an implantable biodegradable drug delivery technology for the delivery of chemotherapy directly into cancer tissues. The company also offers formulation and consultancy services. The c… Read more